BIOSYENT INC earnings per share and revenue

RX earnings per share for the last quarter are 0.20 CAD whereas the estimation was 0.14 CAD which accounts for 42.86% surprise. Company revenue for the same period amounts to 9.56 M CAD despite the estimated figure of 9.00 M CAD. Estimated earnings per share for the next quarter are 0.15 CAD, and revenue is expected to reach 9.10 M CAD. Also watch annual changes over time to get a bigger picture of RX earnings per share and revenue dynamics.